Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SURAKSHA DIAGNOSTIC LIMITED Call Transcript 2025

Feb 3, 2025

62466_rns_2025-02-03_37170e49-918e-4690-a37a-b411bfb579e0.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [141 x 47] intentionally omitted <==

Date: 03 February 2025

To
The Secretary
BSE Limited
Phiroze Jeejeebhoy Towers
Dalal Street
Mumbai - 400 001
Scrip Code: 544293
The Secretary
The National Stock Exchange of India Limited
Exchange Plaza, Plot No. C/1. G Block
Bandra -Kurla Complex, Bandra (East)
Mumbai- 400 051
Scrip Symbol : SURAKSHA

Dear Sir / Ma’am,

Reg: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015

Sub: Intimation of Schedule of Analyst(s) / Institutional Investor(s) Meet/ Conference

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that there will be a Conference Call viz. ‘Earnings Call’ for the Analyst(s)/ Institutional Investor(s) as below:

==> picture [333 x 27] intentionally omitted <==

----- Start of picture text -----

Date Event Mode Type
Monday, 10 February Discussion on Q3 & Conference Group meet
----- End of picture text -----

2025 9M FY25 results call through
digital means

No unpublished price-sensitive information is proposed to be shared during the aforesaid Earnings Call. Discussions at the event will be based on information that are publicly available. The investor presentation on the financial performance of the Company for the quarter and nine months ended 31 December 2024 will be exhibited at the aforesaid meeting and the same shall be duly available on the website of the Company at www.surakshanet.com.

Please note that the schedule of the aforesaid Earnings Call is subject to change. The changes might happen due to exigencies on the part of the Company/ Analyst(s)/ Investor(s).

Further, details as required to be disclosed as per BSE’s Circular No. 20230714-34 dated July 14, 2023, and NSE’s Circular No. NSE/CML/2023/57 dated July 14, 2023, are as under:

Date of occurrence of Event/Information: Monday, 10 February 2025 Time of occurrence of Event/Information: 11.00 am (IST)

Suraksha Diagnostic Limited

(Formerly known as Suraksha Diagnostic Private Limited) CIN: L85110WB2005PLC102265 Reg Office: 12/1, Premises No. 02-0327, DG Block, Action Area 1D, New Town, Kolkata-700 156, West Bengal, India

==> picture [562 x 6] intentionally omitted <==

E-mail: [email protected] I Website: www.surakshanet.com Phone: (033) 6605 9750

==> picture [141 x 47] intentionally omitted <==

The invitation of the aforesaid Earnings Call is enclosed herewith.

This may please be informed to all the concerned.

For Suraksha Diagnostic Limited

MAMTA Digitally signed by MAMTA JAIN JAIN Date: 2025.02.03 17:08:52 +05'30'

_____

Mamta Jain

Company Secretary and Compliance Officer Membership No.: ACS 25654

Encl: As above

Suraksha Diagnostic Limited

(Formerly known as Suraksha Diagnostic Private Limited) CIN: L85110WB2005PLC102265 Reg Office: 12/1, Premises No. 02-0327, DG Block, Action Area 1D, New Town, Kolkata-700 156, West Bengal, India

==> picture [562 x 6] intentionally omitted <==

E-mail: [email protected] I Website: www.surakshanet.com Phone: (033) 6605 9750

SURAKSHA DIAGNOSTIC LIMITED

==> picture [96 x 63] intentionally omitted <==

==> picture [109 x 29] intentionally omitted <==

Suraksha Diagnostic Limited will host a conference call for analysts and investors to discuss their Q3 & 9M FY25 results

Date and Time: Monday, 10[th] February 2025, at 11:00 AM IST

COMPANY PARTICIPANTS

Dr. Somnath Chatterjee (Chairman and Jt. Managing Director)

Ms. Ritu Mittal (Jt. Managing Director and CEO)

Mr. Amit Saraf (Chief Financial Officer)

Mr. Balgopal Jhunjhunwala (GM, Finance)

CONFERENCE DIAL IN NUMBERS

Universal Dial In :

+91 22 6280 1550 / +91 22 7115 8378

International Toll Free:

Hong Kong : 800964448 UK : 08081011573 Singapore : 8001012045 USA : 18667462133

Please pre-register to avoid wait time:

DIAMOND PASS

Please click here for pre-registration

RSVP

==> picture [101 x 29] intentionally omitted <==

Suraksha Diagnostic Limited

Ashish Tendulkar/Pooja Swami +91 9820953312/+91 9860202359 [email protected]/ [email protected]

==> picture [52 x 37] intentionally omitted <==

Orient Capital (a division of Link Group)

Ashish Tendulkar/Pooja Swami +91 9820953312/+91 9860202359 [email protected]/ [email protected]

1